The updated platform, headquartered in Conshohocken, Pennsylvania, replaces the traditional patchwork of disparate vendor logins with a unified interface. By centralizing randomization, drug supply, patient payments, and scheduling, the company aims to reduce manual data reentry and streamline administrative burdens for sponsors and clinical sites. A key technical advancement is the introduction of Sofia, a conversational AI assistant capable of performing permissioned tasks across multiple languages while maintaining full audit logs.
In section Releases
Suvoda Integrates AI and Financial Tools into Unified Clinical Platform
Clinical trial technology provider Suvoda has launched an integrated platform update, merging its RTSM and eCOA systems with financial management tools following its recent acquisition of Greenphire. The release introduces agentic AI capabilities and a centralized dashboard designed to eliminate the fragmented software workflows historically plaguing global research study teams.
Operational efficiency gains are most notable in the platform’s agentic RTSM capabilities, which have demonstrated up to an 80% reduction in kickoff-to-UAT timelines. Furthermore, the new Product Launchpad allows study teams to navigate between eight core products, including eConsent and budgeting tools, without exiting the environment. For patients, the mobile application now supports localized reimbursement options like Alipay, while sites gain automated scheduling and video call functionality to manage home-based visits more effectively. CEO Jagath Wanninayake stated that the integration allows clinical sites to focus less on system reconciliation, ensuring that mission-critical trials maintain momentum through automated, real-time data flow.
Comments (0)
No comments yet. Be the first!